We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




HIV Is Always a Step Ahead of the Immune Response

By Biotechdaily staff writers
Posted on 02 Apr 2003
A recent study has revealed how the body's antibody response stimulates the HIV virus to mutate and escape destruction by the immune system. More...
The study was published March 18, 2003, in the online edition of the Proceedings of the National Academy of Sciences.

Investigators from the University of California, San Diego (USA), cultured viral samples from HIV patients along with antibody-containing plasma samples from the same patients. As blood plasma contains antibodies but no white blood cells, the researchers were able to evaluate the effects of antibodies alone on the virus, independent of the rest of the immune system.

The results from 19 patients over a period of 39 months showed that most patients developed a high titer of antibodies to HIV within a few months, and the antibodies continually evolved in their ability to recognize different antigens on the outer coating of the virus. This evaluation in antibody specificity was necessary because the virus in the plasma continually and rapidly evolved to escape neutralization.

"The neutralizing antibodies are exerting a very strong selective pressure on the virus, and the virus is continually mutating to avoid it,” explained Dr. Douglas D. Richman, a virologist at the University of California, San Diego. "The bad news is that the virus is always staying a step ahead, and the neutralizing antibody response can not control it.”



Related Links:
UC, San Diego

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.